Meeting: 2018 ASCO Annual Meeting Track: Lung Cancer—Non-Small Cell Metastatic Abstract number: LBA4 Authors: Gilberto Lopes, Yi-Long Wu, Iveta Kudaba, et. al. Background: In KEYNOTE-024, pembro significantly improved PFS (primary end point) and OS (secondary end-point) over chemo as first-line therapy for metastatic NSCLC without targetable alterations and PD-L1 TPS ≥50%....
Pro zobrazení tohoto obsahu je třeba být přihlášen.